Module Name Pharmacotherapy 1
Module level, if applicable 3rdYear
Code, if applicable SFA-548
Semester (s) in which the module is taught Fifth Semester
Person responsible for the module Dr. Apt. Vitarani Dwi Ananda Ningrum, M.Si
Lecturer(s) Dr. Apt. Vitarani Dwi Ananda Ningrum, M.Si

apt. Yosi Febrianti, MSc.

Language Bahasa Indonesia and English
Relation to curriculum Compulsory course 
Types of teaching and learning Class size Attendance time (hours per week per semester) Forms of active participation Workload
Teaching, Discussion, Debate  50-60 2 Discussion  Lecture: 2 (hour) x 14 (meeting) 28
Preparation and follow up 4 (hour) x 14 (self-learning)

 

56
Total workload 84 hours
ECTS 3 ECTS
Credit points 2 CU
Requirements according to examination regulations Minimum attendance at lectures is 75% (according to UII regulation). Final score is evaluated based on assignment and reports (40%), mid semester exam (30%), and end semester exam (30%).   
Recommended prerequisites Pharmacology
Related course
Module objectives/intended learning On successful completion of the course students will be able to assess and evaluate a pharmacotherapy from the patient with neurologic disorder, joint disorder, and psychiatric disorder. 
Content The course covers the pathophysiology, therapeutic management (pharmacological and non-pharmacological) and pharmacy practice issues in the management of patients with a range of disorders including:

  1. Pain management 
  2. Epilepsy 
  3. Headache 
  4. Gout 
  5. Osteoarthritis
  6. Rheumatoid Arthritis
  7. Depression 
  8. Anxiety 
  9. Schizophrenia  
Study and examination requirements and forms of examination Mid-term, Final term, assignments and Presentation
Media employed Textbooks, slides (power points), video, Google classroom
Reading lists
  1. Brunton, L., Chabner B., Knollman B., 2011, Goodman &Gilman’s The Pharmacological Basis of Therapeutics, McGraw-Hill
  2. Dipiro, JT., Talbert, RL., Yee, GC., et al, 2017, Pharmacotherapy: a pathophysiologic approach, 10th ed, McGraw-Hill
  3. Lacy, 2018, Drug Information Handbook
  4. www.cochrane.org 
  5. www.nejm.com 
  6. www.bmj.com